Zealand inked a deal worth up to $1.3B to design obesity drugs with Generate Biomedicines’ AI platform.
endpoints.newsZealand inks up to $1.3B deal for AI-designed obesity treatmentsZealand Pharma pays $30M upfront in a deal worth up to $1.3B to design obesity proteins with Generate’s AI platform.
0 reposts1 like